One in six street samples in New South Wales carried an adulterant, and 3.9% contained a novel psychoactive substance.
Across 3,378 seized samples analysed 2021–2025, NPS detections included dipentylone, nitazenes, fentanyl analogues and novel benzodiazepines; median MDMA tablet dose was 104 mg and rising. Chinese forensic chemists separately characterised ZC-B, an azetidine analogue of 2C-B, in seized capsules with no library match.